US Stock MarketDetailed Quotes
CLNN Clene
- 4.1800
- +0.0300+0.72%
Close Nov 29 13:00 ET
- 4.2200
- +0.0400+0.96%
Post 17:01 ET
33.36MMarket Cap-790P/E (TTM)
4.5300High4.0900Low106.15KVolume4.2000Open4.1500Pre Close450.19KTurnover2.62%Turnover RatioLossP/E (Static)7.98MShares12.000052wk High-8.09P/B16.95MFloat Cap3.818152wk Low--Dividend TTM4.06MShs Float356.4000Historical High--Div YieldTTM10.60%Amplitude3.8180Historical Low4.2410Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Clene Stock Forum
Dow Jones· just
Wed, Oct 2, 2024 at 7:21 AM EDT
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community.
LOS ANGELES, CA - (NewMediaWire) - October 2, 2024 - Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal functio...
Clene Announces New CNM-Au8® Biomarker and Clinical Efficacy Data Submitted to FDA In Support of Treatment For ALS
Clene Inc. (Nasdaq: CLNN) has submitted new CNM-Au8 biomarker and clinical efficacy data to the FDA for ALS treatment. Key findings include:
1. CNM-Au8 NfL Responders showed significant improvements in survival, functional status, and combined function and survival.
2. Long-term CNM-Au8 treatmentdemonstrated substantial survival benefits compared to matched cont...
👀👀
plz do something about how ur system calculate RS value...
No comment yet